Search Results
Oct 01, 2025, 08:19 ET Semaglutida oral 25 mg da Novo Nordisk (Wegovy® em comprimido*) proporciona perda de peso de 16,6% em pessoas com obesidade, aponta novo estudo
Wharton S, Lingvay I, Bogdanski P, et al. Oral Semaglutide 25 mg in Adults with Overweight or Obesity. N Engl J Med. 2025; 393:1077-1087. DOI: 10.1056/NEJMoa2500969 Oral Semaglutide 25
More news about: Novo Nordisk
Oct 01, 2025, 05:10 ET VERTANICAL Announces Positive Results From the VER-01 Phase 3 Program for the Treatment of Chronic Low Back Pain (CLBP)
J, Schoder V, Häuser W. Full-spectrum extract from Cannabis sativa DKJ127 for chronic back pain: a randomized, placebo-controlled phase 3 study. Nat Med (2025), published online on September 29, 2025, doi: 10.1038/s41591-025-03977-03 Wu A, March L, Zheng X, et al. Global low back pain
More news about: Vertanical
Oct 01, 2025, 04:48 ET VERTANICAL Announces Positive Results From the VER-01 Phase 3 Program for the Treatment of Chronic Low Back Pain (CLBP)
J, Schoder V, Häuser W. Full-spectrum extract from Cannabis sativa DKJ127 for chronic back pain: a randomized, placebo-controlled phase 3 study. Nat Med (2025), published online on September 29, 2025, doi: 10.1038/s41591-025-03977-03 Wu A, March L, Zheng X, et al. Global low back pain
More news about: Vertanical
Sep 30, 2025, 09:00 ET Zenoti Launches Industry's First AI Workforce for the Beauty, Wellness, and Fitness Industries
Zenoti is the AI-Powered Growth Platform transforming barbershops, salons, spas, med-spas, and gyms worldwide. From single locations to enterprise chains, over 30,000 customers across 50 countries use Zenoti to streamline operations, delight
More news about: Zenoti
Sep 30, 2025, 02:30 ET Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
character that Autoliv, Inc. is obliged to disclose in accordance with the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact persons set out below, on September 30, 2025,
More news about: Autoliv
Sep 30, 2025, 02:22 ET Autoliv Retires Repurchased Shares, Decreases Number of Issued Shares
character that Autoliv, Inc. is obliged to disclose in accordance with the Swedish Financial Instruments Trading Act (Sw. lagen (1991:980) om handel med finansiella instrument). The information was distributed for disclosure, through the agency of the contact persons set out below, on September 30, 2025,
More news about: Autoliv
Sep 26, 2025, 02:30 ET CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
prior RASi trials combined. "The updated KDIGO guidance represents an important step forward for the IgA Nephropathy community," said Prof. Dr. med. Jürgen Floege, Senior Professor, Div. Nephrology and Clinical Immunology at the University Hospital, RWTH Aachen, Germany. "For patients and clinicians,
More news about: Vifor International AG (CSL Vifor)
Sep 26, 2025, 02:30 ET CSL Vifor and Travere Therapeutics Recognize Updated KDIGO Clinical Practice Guidelines for IgA Nephropathy
prior RASi trials combined. "The updated KDIGO guidance represents an important step forward for the IgA Nephropathy community," said Prof. Dr. med. Jürgen Floege, Senior Professor, Div. Nephrology and Clinical Immunology at the University Hospital, RWTH Aachen, Germany. "For patients and clinicians,
More news about: Vifor International AG (CSL Vifor)
Sep 25, 2025, 16:30 ET Zimmer Biomet Announces Japan PMDA Approval of World's First Iodine-Treated Total Hip Replacement System
http://europepmc.org/abstract/MED/28072898
More news about: Zimmer Biomet Holdings, Inc.
Sep 25, 2025, 13:25 ET BMC Medical visar upp innovationer inom sömn- och andningsvård på ERS 2025-kongressen i Amsterdam
kvalitetsprodukter, professionella tjänster och rutiner för förebyggande vård som de använder i sitt dagliga samarbete med familjer över hela världen för att hjälpa dem få bukt med obehaget från kroniska luftvägssjukdomar. Foto –
More news about: BMC Medical Co., Ltd.
Sep 25, 2025, 08:37 ET The Seller's Guide: How to Maximize Valuation When Selling Your Med Spa
dermatology assets and are now allocating capital to med spas. Our job is to put you in front of the right buyers and convert that interest into a premium price, clean terms, and a partner fit you want." The Most Common Mistake Made When Selling A Med Spa The category is young, and consultants
More news about: TUSK Practice Sales
Sep 25, 2025, 08:00 ET Vanda Pharmaceuticals announces the publication in PLOS One of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves sleep in patients with primary insomnia: A multicenter, randomized, double-blind, placebo-controlled trial"
Washington (DC): National Academies Press (US). 2006.Roth T. Insomnia: definition, prevalence, etiology, and consequences. J Clin Sleep Med. 2007;3(5 Suppl):S7-10. pmid:17824495About Vanda Pharmaceuticals Inc. Vanda is a leading global biopharmaceutical company
More news about: Vanda Pharmaceuticals Inc.
Sep 24, 2025, 16:11 ET PRC Announces 2025 Healthcare Leadership Award Recipients
creating a culture where excellence is noticed and shared. Med/Surg Nurses, Floyd County Medical Center Sometimes excellence is measured not just in outcomes, but in moments. At Floyd County Medical Center, the Med/Surg nursing team helped a patient virtually attend his granddaughter's
More news about: PRC
Sep 24, 2025, 14:13 ET Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.Winstedt L, et al. Complete Removal
More news about: Hamlet BioPharma AB
Sep 24, 2025, 14:06 ET Imlifidase successfully meets primary endpoint in pivotal US Phase 3 ConfIdeS trial in kidney transplantation
al. IgG Endopeptidase in Highly Sensitized Patients Undergoing Transplantation. N Engl J Med. 2017 Aug 3;377(5):442-453. doi: 10.1056/NEJMoa1612567. Erratum in: N Engl J Med. 2017 Oct 26;377(17):1700. doi: 10.1056/NEJMx170015.Winstedt L, et al. Complete Removal
More news about: Hamlet BioPharma AB
Sep 24, 2025, 12:43 ET BMC Medical præsenterer innovationer inden for søvn- og respirationsbehandlings på ERS 2025 i Amsterdam
6S Series-masken – Den nyeste maske designet til forbedret komfort og pasform, hvilket er med til at sørge for, at patienterne faktisk bruger den.G3 A20 – En CPAP-enhed med forbedret alsidighed og justeringsevne, der optimerer behandlingsresultaterne.Nye lanceringer af
More news about: BMC Medical Co., Ltd.
Sep 24, 2025, 12:41 ET BMC Medical viser frem innovasjoner innen søvn- og respirasjonsbehandling på ERS 2025 i Amsterdam
klinisk beslutningstaking: Maske i 6S-serien – Neste generasjons maske med forbedret komfort og passform, noe som sikrer bedre etterlevelse for pasienter.G3 A20 – En CPAP-enhet med forbedret tilpasningsevne og personalisering, noe som optimaliserer behandlingsresultatene.Nye
More news about: BMC Medical Co., Ltd.
Sep 24, 2025, 08:41 ET .med Attracts Multimodal AI Ahead of Big Release
time, thousands of .med domains will become publicly available for the first time on a first-come, first-served basis through any accredited .med registrar. .med Domains Powering the Next Wave of AI Medical Innovation The availability of .med domain names is rapidly
More news about: Medistry LLC
Sep 24, 2025, 08:11 ET Międzynarodowe Stowarzyszenie Chirurgii Odtwórczej Włosów organizuje 33. Światowy Kongres, który odbędzie się w dniach 23-25 października 2025 r. w Berlinie w Niemczech, a 26 października odbędą się warsztaty chirurgiczne na żywo, na które bilety zostały już wyprzedane
Dr med. Leslie Castelo-Soccio, USA - „Mikrobiom w odbudowie włosów"Dr med. David Saceda, Hiszpania - „Leczenie łysienia czołowego bliznowaciejącego"Dr med. Ulrike Blume-Peytavi,
More news about: International Society of Hair Restoration Surgery
Sep 24, 2025, 07:50 ET ProRx Pharma Awarded DEA Controlled Substances Registration Certificate
committed to delivering safe, compliant, and high-quality compounded sterile and nonsterile preparations to physician practices, medical clinics, and med spas across the country. With a focus on preventative health, regulatory excellence, reliability, and customer service, ProRx partners with providers
More news about: ProRx Pharma
Sep 23, 2025, 09:57 ET Georgia College ranked among Top Five in South by U.S. News & World Report
Pre-Med Mentoring Program, for instance, have generated a 100% placement rate into medical school for each of the past 15 years. And scholar-athletes
More news about: Georgia College & State University
Sep 23, 2025, 09:07 ET CBD Genesis Celebrates One Year Under Women-Owned Leadership with New Innovations
and Metabolism + Gut Health—crafted to support everyday balance beyond hemp.Retail Growth on the Rise: From spas and med spas to wellness retailers nationwide, CBD Genesis is expanding its footprint and building a loyal following wherever plant-powered wellness is needed
More news about: CBD Genesis
Sep 23, 2025, 09:00 ET PENTAX Medical and ASP Launch the Sterilizable DEC™ Duodenoscope: A Revolutionary Reusable Duodenoscope with 68-Minute Sterilization
https://www.pentaxmedical.com About HOYA Founded in 1941 in Tokyo, Japan, HOYA Corporation is a global technology and med-tech company and a leading supplier of innovative high-tech and medical products. HOYA is active in the fields of lifecare and information technology,
More news about: PENTAX Medical
Sep 23, 2025, 08:30 ET Rapid Nexus Unveils First-Ever Medical Technology to Regrow Nerves and Stop Amputations in Diabetic Patients
Sept. 23, 2025 /PRNewswire/ -- Rapid Nexus, a California-based med-tech company, has unveiled the first medical device proven to regenerate nerves and reverse chronic wounds — offering a long-awaited solution for millions
More news about: Rapid Nexus
Sep 23, 2025, 00:30 ET Neuromod Advance Multiple Regulatory Approvals to Expedite Global Availability of Lenire
Lim, H. Retrospective chart review demonstrating effectiveness of bimodal neuromodulation for tinnitus treatment in a clinical setting, Commun Med (2025). 3. Brendan Conlon et al. Bimodal neuromodulation combining sound and tongue stimulation reduces
More news about: Neuromod Devices